Atea Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Atea Pharmaceuticals's balance sheet done over the years? Its assets were worth $594,968,000 last year, which is less than in the previous period. 7% of Atea Pharmaceuticalsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $39,776,000, which means an increase by 52% compared compared to last year.

Debt to Assets

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR): Debt to assets
2018 34861000 71.02M 203.73%
2019 22073000 71.64M 324.58%
2020 863632000 315.83M 36.57%
2021 772892000 62.81M 8.13%
2022 666708000 26.13M 3.92%
2023 594968000 39.77M 6.69%

AVIR Balance Sheet (2018 โ€“ 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
143.82M646.70M764.37M850.11M21.66M34.49M
Short term investments
434.28M458.24M0000
Net receivables
0005.81M00
Inventory
000000
Other current assets
12.34M14.21M8.02M7.54M249K206K
Total current assets
590.45M660.92M772.40M863.47M21.91M34.69M
Non-current assets:
Property, Plant and Equipment
3.11M4.09M23K48K41K56K
Goodwill
000000
Intangible assets
000000
Long term investments
0198K305K107K107K0
Other non-current assets
1.39M1.49M161K015K107K
Total non-current assets
4.51M5.78M489K155K163K163K
Total assets
594.96M666.70M772.89M863.63M22.07M34.86M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00-197K301.36M200K0
Short term debt
760K721K197K0-200K0
Total current liabilities
32.37M18.47M56.88M315.79M2.43M1.76M
Non-current liabilities:
Long term debt
1.64M2.40M0000
Deferred tax
000000
Other non-current liabilities
5.75M5.25M5.93M36K69.20M69.26M
Total non-current liabilities
7.4M7.65M5.93M36K69.20M69.26M
Total liabilities
39.77M26.13M62.81M315.83M71.64M71.02M
Data sourceData sourceData source